Private company
Logo: Nahian, Public domain, via Wikimedia Commons3
Bangladeshi pharmaceutical company
Eskayef Pharmaceuticals Ltd., also known as SK+F, is a pharmaceutical company in Bangladesh. It belongs to the Transcom Group. Simeen Rahman is the managing director and CEO of the company.2 It was founded by Latifur Rahman.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
See how the biggest companies compare on our leaderboards
Eskayef Pharmaceuticals Ltd., also known as SK+F, is a pharmaceutical company in Bangladesh. It belongs to the Transcom Group. Simeen Rahman is the managing director and CEO of the company.2
Founded by Latifur Rahman in 1990.1
Eskayef Bangladesh Ltd., a successor of Smith, Kline & French in Bangladesh, was acquired by Transcom in 1990. According to an IMS report, the company was among the top six pharmaceutical companies operating in Bangladesh in terms of sales in 2021. By 2021, it exported finished products to 65 countries. The company was renamed Eskayef Pharmaceuticals Limited in January 2017.
From Wikipedia’s article on SK+F, shared under CC BY-SA 4.0.4
Who has led Eskayef Bangladesh Limited, and when. Pick a name to see everywhere that person has worked.
The company is engaged in the manufacture and marketing of a wide range of therapeutic drugs, bulk pellets and animal health and nutrition products including the oral anti covid medication molnupiravir & nirmatrelvir co-packaged with ritonavir and injectable remdesivir. Losectil (Omeprazole) by Eskayef is an anti-ulcerant proton pump inhibitor that suppresses stomach acid to treat GERD, ulcers, and heartburn.
From Wikipedia’s article on SK+F, shared under CC BY-SA 4.0.4
The numbers on this page point here. Each one links to the record it came from.
